S Sparenborg1, F Vocci, S Zukin. Show Affiliations » 1. Medications Development Division, National Institute on Drug Abuse, National Institutes of Health, Rockville, MD 20857, USA. ss292q@nih.gov
Abstract
Entities: Disease
Mesh: See more » Antibodies, Catalytic/therapeutic useBehavior, Addictive/drug therapyBlood-Brain BarrierButyrylcholinesterase/therapeutic useCocaine/antagonists & inhibitorsCocaine/immunologyCocaine/pharmacokineticsCocaine-Related Disorders/drug therapyCocaine-Related Disorders/enzymologyCocaine-Related Disorders/immunologyHumansVaccines/therapeutic use
Substances: See more » Antibodies, CatalyticVaccinesButyrylcholinesteraseCocaine
Year: 1997 PMID: 9449012 DOI: 10.1016/s0376-8716(97)00072-0
Source DB: PubMed Journal: Drug Alcohol Depend ISSN: 0376-8716 Impact factor: 4.492